|
1006
|
Infanrix-IPV+Hib vaccine
|
Diphtheria
|
Corynebacterium diphtheriae
|
Conjugate
|
GlaxoSmithKline Biologicals S.A
|
Approved
|
Intramuscular
|
NA
|
NCT01309646
|
|
1020
|
Infanrix hexa
|
Diphtheria
|
Corynebacterium diphtheriae
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NCT01353703
|
|
1040
|
Infanrix-IPV+Hib
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Conjugate
|
GlaxoSmithKline Biologicals S.A
|
Approved
|
Intramuscular
|
NA
|
NCT01309646
|
|
1050
|
Infanrix hexa
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NCT01353703
|
|
1066
|
Infanrix-IPV+Hib
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Conjugate
|
GlaxoSmithKline Biologicals S.A
|
Approved
|
Intramuscular
|
NA
|
NCT01309646
|
|
1082
|
Infanrix hexa
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NCT01353703
|
|
1118
|
Typbar TCV
|
Typhoid
|
Salmonella typhi
|
Conjugate
|
Bharat Biotech
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1119
|
TYPHIBEV
|
Typhoid
|
Salmonella typhi
|
Conjugate
|
Biological E
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1120
|
PedaTyph
|
Typhoid
|
Salmonella typhi
|
Conjugate
|
BIO-MED Private Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1121
|
Zyvac TCV
|
Typhoid
|
Salmonella typhi
|
Conjugate
|
Cadila Healthcare Ltd
|
Approved
|
Intramuscular
|
32134011, 32725225
|
NA
|
|
1128
|
MenQuadfi
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
Sanofi Pasteur Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1130
|
MenHibrix
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1131
|
Menitorix
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1132
|
Nimenrix
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
Pfizer
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1133
|
Menjugate
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
GSK Vaccines S.r.l.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1134
|
Meningitec
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
Wyeth Pharmaceuticals
|
Approved
|
Intramuscular
|
12675020
|
NA
|
|
1137
|
NEISVAC-C
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
Pfizer
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1139
|
Prevnar 20
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
Pfizer
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1143
|
VAXNEUVANCE
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
Merck Sharp & Dohme Corp.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1144
|
Synflorix
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1145
|
Pneumosil
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
By collaboration between Serum Institute of India Pvt Ltd and PATH.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1149
|
OmniHib
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
Pasteur Mérieux Serums & Vaccins S. A.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1150
|
MenHibrix
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1151
|
PedvaxHib
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
Merck and Co. , INC.
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1153
|
Menitorix
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1154
|
Infanrix hexa
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NCT01353703
|
|
1156
|
HibTITER
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
Lederle-Praxis
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1157
|
ProHIBiT
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
Connaught
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1158
|
Infanrix-IPV+Hib
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
GlaxoSmithKline Biologicals S.A
|
Approved
|
Intramuscular
|
NA
|
NCT01309646
|
|
1160
|
Vaxem Hib
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
Novartis Vaccines & Diagnostics S.r.l and GlaxoSmithKline
|
Approved
|
Intramuscular
|
NA
|
NA
|
|
1181
|
StaphVAX
|
Methicillin-Resistant Staphylococcus aureus (MRSA)
|
Staphylococcus aureus
|
Conjugate
|
Nabi Biopharmaceuticals
|
Clinical - Failed
|
NA
|
12054071
|
NCT00071214
|
|
1183
|
Pentastaph
|
Methicillin-Resistant Staphylococcus aureus (MRSA)
|
Staphylococcus aureus
|
Conjugate
|
NABI/GSK
|
Clinical - Failed
|
NA
|
21501445
|
NA
|
|
1187
|
Sonnei vaccine 1790GAHB
|
Bacillary Dysentery (Shigellosis)
|
Shigella genus
|
Conjugate
|
GlaxoSmithKline
|
Clinical - Phase 1
|
Intramuscular
|
NA
|
NCT03089879
|
|
1189
|
SF2a-TT15
|
Bacillary Dysentery (Shigellosis)
|
Shigella genus
|
Conjugate
|
University of Maryland, Baltimore
|
Clinical - Suspended
|
Intramuscular
|
33186516
|
NCT04078022
|
|
1190
|
Shigella Conjugate
|
Bacillary Dysentery (Shigellosis)
|
Shigella genus
|
Conjugate
|
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
Clinical - Phase 3
|
NA
|
11179298
|
NCT00368316
|
|
1192
|
O-SPC/rBRU
|
Bacillary Dysentery (Shigellosis)
|
Shigella genus
|
Conjugate
|
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
Clinical - Phase 1
|
Intramuscular
|
NA
|
NCT01369927
|
|
1204
|
S.Flexneriza-S.Sonnei Bivalent
|
Bacillary Dysentery (Shigellosis)
|
Shigella genus
|
Conjugate
|
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT04865497
|
|
1207
|
CJCV1
|
Campylobacteriosis
|
Campylobacter genus
|
Conjugate
|
U.S. Army Medical Research and Development Command
|
Clinical - Phase 1
|
Intramuscular
|
30252591
|
NCT02067676
|
|
1226
|
GBS Trivalent vaccine
|
Streptococcal Disease, Group B
|
Streptococcus agalactiae (Group B Streptococcus)
|
Conjugate
|
GlaxoSmithKline
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT02270944
|
|
1227
|
GBS Trivalent vaccine
|
Streptococcal Disease, Group B
|
Streptococcus agalactiae (Group B Streptococcus)
|
Conjugate
|
Novartis
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT01446289
|
|
1253
|
V441
|
Diphtheria
|
Corynebacterium diphtheriae
|
Conjugate
|
Merck Sharp & Dohme Corp.
|
Clinical - Phase 3
|
NA
|
NA
|
NCT00092469
|
|
1259
|
Eupenta Inj.
|
Diphtheria
|
Corynebacterium diphtheriae
|
Conjugate
|
LG Chem
|
Clinical - Phase 4
|
NA
|
NA
|
NCT04056728
|
|
1279
|
Eupenta Inj.
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Conjugate
|
LG Chem
|
Clinical - Phase 4
|
NA
|
NA
|
NCT04056728
|
|
1288
|
V441
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Conjugate
|
Merck Sharp & Dohme Corp.
|
Clinical - Phase 3
|
NA
|
NA
|
NCT00092469
|
|
1299
|
Eupenta Inj.
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Conjugate
|
LG Chem
|
Clinical - Phase 4
|
NA
|
NA
|
NCT04056728
|
|
1315
|
V441
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Conjugate
|
Merck Sharp & Dohme Corp.
|
Clinical - Phase 3
|
NA
|
NA
|
NCT00092469
|
|
1325
|
TyVEGHA
|
Typhoid
|
Salmonella typhi
|
Conjugate
|
International Vaccine Institute
|
Clinical - Phase 4
|
NA
|
NA
|
NCT04852185
|
|
1326
|
PQed
|
Typhoid
|
Salmonella typhi
|
Conjugate
|
PT Bio Farma
|
Clinical - Phase 3
|
NA
|
NA
|
NCT04051268
|
|
1327
|
Vi-TCV
|
Typhoid
|
Salmonella typhi
|
Conjugate
|
University of Maryland, Baltimore
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT03299426
|
|
1328
|
Vi-DT
|
Typhoid
|
Salmonella typhi
|
Conjugate
|
International Vaccine Institute
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT03933098
|
|
1330
|
EuTCV
|
Typhoid
|
Salmonella typhi
|
Conjugate
|
EuBiologics Co.,Ltd
|
Clinical - Phase 2, Phase 3
|
Intramuscular
|
NA
|
NCT04830371
|
|
1331
|
M01ZH09
|
Typhoid
|
Salmonella typhi
|
Conjugate
|
University of Oxford
|
Clinical - Phase 2
|
Oral
|
NA
|
NCT01405521
|
|
1332
|
Vi-rEPA
|
Typhoid
|
Salmonella typhi
|
Conjugate
|
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
Clinical - Phase 2
|
NA
|
NA
|
NCT00342628
|
|
1336
|
Typhax
|
Typhoid
|
Salmonella typhi
|
Conjugate
|
Matrivax Research and Development Corporation
|
Clinical - Phase 1
|
Intramuscular
|
31905228
|
NCT03926455
|
|
1340
|
NmCV-5
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
Serum Institute of India Pvt. Ltd.
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT03964012
|
|
1341
|
MenCC-BIO
|
Meningococcal disease
|
Neisseria meningitidis
|
Conjugate
|
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
|
Clinical - Phase 2, Phase 3
|
NA
|
NA
|
NCT02858570
|
|
1343
|
V114
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
Merck Sharp & Dohme Corp.
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT03547167
|
|
1344
|
NBP606
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
SK Chemicals Co., Ltd.
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT02201030
|
|
1345
|
PCV13i
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
CanSino Biologics Inc.
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT04841369
|
|
1347
|
LBVE
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
LG Chem
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT03467984
|
|
1348
|
PNCRM9
|
Pneumococcal
|
Streptococcus pneumoniae
|
Conjugate
|
National Institute of Allergy and Infectious Diseases (NIAID)
|
Clinical - Phase 2
|
Intramuscular
|
NA
|
NCT00133549
|
|
1350
|
Eupenta Inj.
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
LG Chem
|
Clinical - Phase 4
|
NA
|
NA
|
NCT04056728
|
|
1361
|
Minhai-HIB
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
Beijing Minhai Biotechnology Co., Ltd
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT02560272
|
|
1362
|
LBVH0101
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Conjugate
|
LG Life Sciences
|
Clinical - Phase 3
|
NA
|
NA
|
NCT01019772
|